Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine effect on sufentanil EC50 during tracheal intubation for laparoscopic surgery
ChiCTR2600131771Phase 4Not yet recruiting
- Sponsor
- Chongqing Health Center for Women and Children
- Start
- Aug 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine and sufentanil (4 arms), sponsored by Chongqing Health Center for Women and Children. Primary endpoints: Mean arterial pressure, Heart rate and 1 more. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
esketaminesufentanil
Beyond the preview
Go deeper on ChiCTR2600131771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600131771.